An Efficacy and Safety Study of Abiraterone Acetate and Prednisone in Participants With Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy

NCT00485303 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostatic Neoplasms
Prostate Cancer

Interventions

DRUG: Abiraterone acetate
DRUG: Prednisone

Sponsor

Cougar Biotechnology, Inc.